Oruka Therapeutics, Inc. financial data

Symbol
ORKA on Nasdaq
Location
Menlo Park, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2,448 % +1.2%
Debt-to-equity 3.96 % -39.8%
Return On Equity -27.06 % +57%
Return On Assets -26.03 % +37%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48,409,232 shares +38.3%
Common Stock, Shares, Outstanding 48,384,150 shares +38.2%
Entity Public Float 39,700,000 USD +89.8%
Common Stock, Value, Issued 48,000 USD +37.1%
Weighted Average Number of Shares Outstanding, Basic 42,095,951 shares +12.2%
Weighted Average Number of Shares Outstanding, Diluted 42,095,951 shares +12.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Research and Development Expense 103,531,000 USD +1.3%
General and Administrative Expense 18,788,000 USD +80%
Operating Income (Loss) -122,319,000 USD -1.2%
Nonoperating Income (Expense) 16,307,000 USD +3.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -106,699,000 USD -97.7%
Earnings Per Share, Basic 2 USD/shares +93.4%
Earnings Per Share, Diluted 2 USD/shares +93.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91,253,000 USD -77.8%
Marketable Securities, Current 257,902,000 USD
Other Assets, Current 537,000 USD -10.4%
Assets, Current 355,163,000 USD -14%
Property, Plant and Equipment, Net 253,000 USD +58.1%
Operating Lease, Right-of-Use Asset 1,969,000 USD +1.1%
Other Assets, Noncurrent 103,000 USD +1.4%
Assets 509,251,000 USD +23%
Accounts Payable, Current 571,000 USD +1.4%
Employee-related Liabilities, Current 109,000 USD -42.6%
Liabilities, Current 20,967,000 USD +16.2%
Operating Lease, Liability, Noncurrent 1,493,000 USD +77.3%
Liabilities 22,460,000 USD +19%
Accumulated Other Comprehensive Income (Loss), Net of Tax 185,000 USD
Retained Earnings (Accumulated Deficit) -159,574,000 USD -1.8%
Stockholders' Equity Attributable to Parent 486,791,000 USD +42.2%
Liabilities and Equity 509,251,000 USD +23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20,869,000 USD -12.7%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 545,000,000 shares 0%
Common Stock, Shares, Issued 48,384,150 shares +38.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1,528,000 USD +4.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 91,253,000 USD -77.8%
Deferred Tax Assets, Valuation Allowance 21,317,000 USD -61.6%
Deferred Tax Assets, Gross 21,501,000 USD -61.3%
Operating Lease, Liability 1,912,000 USD +93.5%
Depreciation 16,000 USD
Payments to Acquire Property, Plant, and Equipment 13,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -101,446,000 USD -5%
Lessee, Operating Lease, Liability, to be Paid 2,333,000 USD +78.6%
Property, Plant and Equipment, Gross 222,000 USD -3.1%
Operating Lease, Liability, Current 419,000 USD +1.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 768,000 USD +55.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 822,000 USD +1.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 421,000 USD +32.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 397,000 USD +4.5%
Deferred Tax Assets, Operating Loss Carryforwards 2,260,000 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits 1,047,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 304,000 USD
Operating Lease, Payments 63,000 USD +1.7%
Additional Paid in Capital 643,201,000 USD +61.9%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 63,000 USD -29.2%
Share-based Payment Arrangement, Expense 25,246,000 USD +1.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%